Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Total Liabilities (2020 - 2025)

IceCure Medical (ICCM) has disclosed Total Liabilities for 5 consecutive years, with $5.7 million as the latest value for Q4 2024.

  • On a quarterly basis, Total Liabilities rose 33.62% to $5.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.7 million, a 33.62% increase, with the full-year FY2024 number at $5.7 million, up 33.62% from a year prior.
  • Total Liabilities was $5.7 million for Q4 2024 at IceCure Medical, up from $4.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $5.7 million in Q4 2024 to a low of $4.2 million in Q4 2023.
  • A 5-year average of $4.9 million and a median of $4.8 million in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: decreased 10.89% in 2023, then soared 33.62% in 2024.
  • IceCure Medical's Total Liabilities stood at $4.6 million in 2020, then grew by 15.94% to $5.3 million in 2021, then fell by 10.46% to $4.8 million in 2022, then dropped by 10.89% to $4.2 million in 2023, then skyrocketed by 33.62% to $5.7 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Total Liabilities are $5.7 million (Q4 2024), $4.2 million (Q4 2023), and $4.8 million (Q4 2022).